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Abstract
Understanding how autocrine/paracrine factors regulate neural stem cell (NSC) survival and growth is fundamental to the
utilization of these cells for therapeutic applications and as cellular models for the brain. In vitro, NSCs can be propagated
along with neural progenitors (NPs) as neurospheres (nsphs). The nsph conditioned medium (nsph-CM) contains cell-
secreted factors that can regulate NSC behavior. However, the identity and exact function of these factors within the nsph-
CM has remained elusive. We analyzed the nsph-CM by mass spectrometry and identified DSD-1-proteoglycan, a
chondroitin sulfate proteoglycan (CSPG), apolipoprotein E (ApoE) and cystatin C as components of the nsph-CM. Using
clonal assays we show that CSPG and ApoE are responsible for the ability of the nsph-CM to stimulate nsph formation
whereas cystatin C is not involved. Clonal nsphs generated in the presence of CSPG show more than four-fold increase in
NSCs. Thus CSPG specifically enhances the survival of NSCs. CSPG also stimulates the survival of embryonic stem cell (ESC)-
derived NSCs, and thus may be involved in the developmental transition of ESCs to NSCs. In addition to its role in NSC
survival, CSPG maintains the three dimensional structure of nsphs. Lastly, CSPG’s effects on NSC survival may be mediated
by enhanced signaling via EGFR, JAK/STAT3 and PI3K/Akt pathways.
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Introduction
In vivo, neural stem cells (NSCs) reside in tightly regulated
microenvironments known as the stem cell niche. This niche
consists of supporting niche cells, extrinsic signals, membrane-
bound molecules and the extracellular matrix (ECM). The niche
protects stem cells from differentiation signals, apoptotic stimuli and
excessive proliferation which can result in cancer [1]. In vitro,N S C s
can be propagated along with lineage restricted neural progenitors
(NPs) as neurospheres (nsphs) or adherent cultures. The nsph
conditioned medium (nsph-CM) contains cell-secreted factors that
have been shown to increase NSC/NP survival and proliferation
[2–3]. Nsph-CM also regulates cell fate decisions [4–5]. Beside
soluble factors, proteoglycans within the ECM are known to act as
reservoirs for growth factors [6].
Proteoglycans are proteins with covalently-bound sulfated glycos-
aminoglycans (GAGs). In the central nervous system (CNS),
proteoglycans carry mainly chondroitin sulfate (CS) or heparan
sulfate (HS) GAGs [6]. During development, CSPGs regulate cell
division [7–8], neural crest cell migration [9–10] and axon path
finding [11–14]. In addition, there is increasing evidence that CSPGs
regulate NSC/NP proliferation.NSCs/NPssecreteCSPGs including
phosphacan, aggrecan and neurocan [15]. NSCs/NPs expressing the
DSD-1-proteoglycan (also known as phosphacan) showed increased
nsph formation and neurogenesis [16], whereas disruption of CS-
GAGs with chondroitinase ABC (chABC) treatment reduces NSC/
NP proliferation, secondary nsph formation and neurogenesis.
ChABC injected into the embryonic ventricular zone disrupts the
cellular architecture of this region and inhibits NSC/NP proliferation
[17]. However, the exact role of cell-secreted CSPG remains unclear.
Does it affect NSCs, NPs or both and what signaling pathways does
CSPG utilize for its effects on NSCs/NPs?
In the present work, we used nsph cultures containing both NSCs
and NPs to evaluate the role of nsph-CM on NSC survival. We
show by mass spectrometry that nsph-CM contains CSPG, ApoE
and cystatin C. The nsph stimulatory effect of nsph-CM can be
attributed to CSPG and ApoE but not cystatin C. We show that
exogenous CSPG added to NSCs/NPs at clonal densities increases
nsph number and size. Using clonal analysis and assays for self-
renewal and multipotency, we show that CSPG stimulates
specifically NSC survival. In addition, CSPG also enhances the
survival of embryonic stem cell (ESC)-derived NSCs. ChABC
treatment disrupts the 3-dimentional (3D) structure of nsphs,
suggesting a role for CSPG in maintaining nsph integrity. Lastly, we
show that CSPG is likely to increase NSC survival via enhancement
of the epidermal growth factor receptor (EGFR), Janus kinase/
signal transducers and activator of transcription 3 (JAK/STAT3)
and phosphoinositide-3-kinase/Akt (PI3K/Akt) signaling pathways.
Materials and Methods
Isolation and culturing of NSCs/NPs
All animal experiments were approved by the Biomedical
Research Council Singapore, Institutional Animal Care and Use
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guidelines. NSCs/NPs were isolated from embryonic (E14.5)
C57BL/6 mice. Dissociated cortical cells were seeded at 2610
5
cells/ml in NSC growth medium (GM) [Dulbecco’s Modified
Eagle’s Medium (DMEM)/F-12, N2 supplement, 20 ng/ml EGF
and 1% penicillin/streptomycin (all from Invitrogen)]. Cells were
grown at 37uC and 5% CO2 atmosphere in a humidified incubator.
Nsphs were passaged every 5–7 days. Bulk density cultures were at
2610
4 cells/ml and low density cultures were at 2610
3 cells/ml
(equivalent to 350cells/cm
2). We estimate that under low density
culture conditions approximately 98% of nsphs are clonal based on
the following calculation. Based on a recent publication, the
estimated aggregation rates for cells cultured at 1610
3 cells/ml
(250cells/cm
2)a n d5 610
3 cells/ml (1250cells/cm
2) are 1.6% and
8% respectively, when cells were not disturbed during the culturing
period [18]. Thus there is a five-fold increase in aggregation rate
with a five-fold increase in cell density. For our experiments, the cell
density is 1.4-fold higher than the lower density used by Coles-
Takabe et al. (2008). In addition, our cells were also not disturbed
duringtheculturingperiod,thus the aggregation rate inourcultures
is estimated to be 2.2% (i.e. 1.4-fold higher than the 1.6%
aggregation rate for cells cultured at 1610
3 cells/ml). This indicates
that approximately 98% of the nsphs were likely to be clonal. For
hydrogel cultures dissociated cells were plated at 2.5610
3 cells/ml
in a 1.2% hydrogel/GM solution. For adherent cultures, dissociated
cells were plated at 1610
4 cells/ml on 0.1% poly-L-lysine (PLL;
Sigma) coated plates. Growth curves were generated using the
CellTitre Glo cell viability assay (Promega).
Nsph-CM
Nsph-CM was collected on day five. Nsph-CM and GM were
fractionated into proteins greater than (Fraction A) and less than
(Fraction B) 30 kDa using Amicon filters (Millipore). The fractions
were digested with trypsin (Promega) in 50 mM ammonium
bicarbonate (pH 8.0) and 2% acetonitrile overnight at 37uC. The
digested peptides were analyzed using a Q-STAR liquid chroma-
tography mass spectrometer and compared with the same fractions
from GM. The six sub-fractions were obtained by elution through a
liquid chromatography column with a water stationary phase and
an acetonitrile mobile phase, and separated into individual factions
based on elution time. The fractions were decontaminated and
reconstituted back into GMto the original concentration foractivity
analysis. Digestion of nsph-CM was carried out with 5 mU/ml
chABC (Sigma) overnight at 37uC followed by heat inactivation at
100uC for 5 min. ApoE (Calbiochem) was used at 50 nM and RAP
(Innovative Research) at 5 mM.
CSPG and inhibitors
Since purified forms of CSPG e.g. DSD-1-proteoglycan, is not
commercially available, we used proteoglycan from bovine nasal
septum (Sigma). This preparation consist of 86% chondroitin
sulfate, 8% protein, 6% keratan sulfate and less than 1%
hyaluronic acid [19]. Unless stated otherwise, all experiments
with CSPG (Proteoglycan from bovine nasal septum; Sigma) and
CS-GAGs were done in low-density cultures (2610
3 cells/ml),
while all CSPG inhibitors were tested in bulk-density cultures
(2610
4 cells/ml). ChABC, sodium chlorate, 4-methylumbelliferyl-
b-D-xyloside and keratanase (all from Sigma), PD168393,
LY294002, AG490, PD98059 and Y27632 (Calbiochem) and
C3 (Cytoskeleton) were used at the stated concentrations. CSPG,
CS-A & -C (Sigma), -B, -D & -E (US Biological) and KS (US
Biological) were used at 50 mg/ml. All reagents were added at time
of cell plating and left for the duration of the culture. Nsph
formation was assessed after 5 days by manually counting and
sizing all the nsphs in the well.
ESC derived NSCs
D3 mouse ESCs were grown on mouse embryonic feeder (MEF)
layer in ESC medium [DMEM containing 15% fetal bovine serum
(FBS), b-mercaptoethanol, non-essential amino acids, glutamine
(all Invitrogen) and 1,000 U/ml leukemia inhibitory factor
(Chemicon)]. After the removal of MEF, ESCs were seeded at
10
5 cells/ml in NSC growth medium. Spheres were passaged
every 7 days and their numbers assessed after 21 days.
Differentiation and immunocytochemistry
Single nsphs from low density cultures were transferred to each
well of a 50-well cover glass (Sigma) coated with PLL (0.01%) and
laminin (10 mg/ml; Invitrogen). Nsphs were differentiated for five
days in differentiation medium [DMEM/F-12, N2, 1% penicillin/
streptomycin and 0.5% FBS (Invitrogen)]. Cells were stained with
mouse IgM anti-O4 (1:300; Chemicon), mouse IgG2a anti-Tuj1
(bIII-tubulin; 1:250; Covance) and rabbit IgG anti-GFAP (1:1000;
Dako). The secondary antibodies were Alexa Fluor antibodies 488
anti-mouse IgM, 594 anti-mouse IgG2a and 647 anti-rabbit IgG
(1:500; Invitrogen). Cells were counter stained with DAPI
(Invitrogen) and scored based on staining and morphology.
Western Blot
Dissociated cells were plated in medium without EGF for
3 hours then stimulated with EGF (20 ng/ml), CSPG (50 mg/ml)
or CSPG and EGF for the length of time stated. Alternatively,
nsphs generated with/without CSPG were harvested after 6 days
in culture. Proteins were extracted and transferred to PVDF
membrane as previously described [20]. Membranes were
immunoblotted with antibodies to the following proteins: phos-
photyrosine (PY20) and EGFR (BD Pharmingen); phospho-EGFR
(Tyr 1068), phospho-STAT3 (Tyr 705), STAT3, phospho-Akt
(Thr308), Akt (Cell Signaling).
Data analysis
Results are presented as mean 6 SEM. Data were analyzed
with paired Student T-test. Relative gene expression was
calculated using the ABI Relative Quantitation Algorithm
(Applied Biosystems). Multiple sets of data were combined by a
stratified t-test [21]. Growth curves and inhibitor dose-dependent
curves were fitted by GraphPad Prism software. Images were
taken with the Olympus point scanning FV-1000 confocal
microscope.
Results
Nsph-CM stimulates nsph formation
The standard culture condition for nsphs includes the B-27
supplement, bFGF and EGF. In such rich culture media it is
difficult to study the effect of cell secreted factors by mass
spectrometry mainly because of protein complexes formed in the
presence of BSA. Thus we utilized a minimal media containing the
N2 supplement and EGF alone. Under such condition we
observed that nsph-CM stimulated nsph formation at various cell
densities from clonal (10 cells/ml, equals 1 cell/well) to 1610
4
cells/ml (Fig. 1A). We fractionated the nsph-CM into fraction A
(.30 kDa) and fraction B (,30 kDa; Fig. 1B) and found that in
low density cultures fraction A has nsph stimulatory activity
approximating that of whole nsph-CM, and fraction B stimulated
nsph formation by 1.5-fold (Fig. 1C). The concentrated fractions A
and B of nsph-CM were compared with the appropriate fractions
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proteoglycan (also known as phosphacan), apolipoprotein E
(ApoE) and cystatin C were identified as unique factors present
in the nsph-CM (Fig. 1D).
CSPG and ApoE is responsible for the nsph stimulatory
effect of nsph-CM
To determine which of the identified proteins is likely to
contribute to the nsph stimulatory effect of nsph-CM, we further
fractionated fractions A and B (Fig. 2A). Fraction A was
fractionated into sub-fractions 1 (240–180 kDa), 2 (180–
120 kDa) and 3 (120–60 kDa). Sub-fractions 1 and 2 displayed
nsph stimulatory activity similar to whole nsph-CM whereas sub-
fraction 3 did not stimulate nsph formation (Fig. 2B). Fraction B
was fractionated into sub-fractions 4 (60–40 kDa), 5 (40–20 kDa)
and 6 (20–3 kDa). Sub-fractions 4 and 5 have similar nsph
stimulatory activity as fraction B whereas sub-fraction 6 had no
nsph stimulatory effect (Fig. 2B). This suggests that the stimulatory
proteins are between 120–240 kDa and 20–60 kDa. From our list
of identified proteins, DSD-1-proteoglycan is a CSPG with a
calculated size of 173 kDa, ApoE is approximately 33 kDa, and
cystatin C is approximately 13 kDa. Thus CSPG and ApoE are
potential candidates responsible for the nsph-CM stimulation of
nsph formation. To test our hypothesis, exogenous CSPG, ApoE
Figure 1. Identification of CSPG, ApoE and Cystatin C in nsph-CM. (A) Cells were plated at different densities (between 10 cells/ml to 2610
4
cells/ml) in growth medium (GM) or neurosphere-conditioned medium (nsph-CM) and nsph forming units (NFUs) measured after five days of culture.
NFU is the number of nsph formed divided by number of cells seeded x 100. The cell density of 10 cells/ml represents 1 cell per well. The data are
presented as the mean 6 SEM with n$6 (from 3 experiments), **P#0.01 compared to GM at each concentration. (B) After removal of cell debris and
whole cells, nsph-CM was concentrated 2500-fold and size fractionated into two parts; proteins .30 kDa (fraction A) and ,30 kDa (fraction B).
Fraction B was further concentrated 2500-fold as described in the Materials and Methods section. (C) Cells were plated at 2610
3 cells/ml in GM, nsph-
CM, fraction A or fraction B. Nsph-CM, fractions A and B were reconstituted into GM to the original concentration prior to cell culture. Data are
presented as mean 6 SEM with n$6 (from 3 experiments); *P#0.05, **P#0.01 compared to GM. (D) Fractions A and B derived from GM and nsph-CM
were digested with trypsin and the mass of peptides evaluated using liquid chromatography-mass spectrometry (LCMS). The table shows peptide
sequences unique to nsph-CM leading to the identification of DSD-proteoglycan, apolipoprotein E and cystatin C.
doi:10.1371/journal.pone.0015341.g001
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exogenous CSPG and ApoE individually can recapitulate the
effects of fractions A and B of nsph-CM respectively, and together
reproduced the effect of the whole nsph-CM (Fig. 2C). Exogenous
cystatin C did not stimulate nsph formation as expected, so this
protein was not evaluated further. Cystatin C did however
increase nsph size (NSC/NP proliferation; data not shown). To
further confirm the role of CSPG, the nsph-CM was treated with
chABC to digest the CS-GAGs, followed by heat inactivation of
the enzyme. This chABC treatment resulted in a 51% reduction of
the stimulatory effect of nsph-CM (Fig. 2D). Similar chABC
treatment of GM did not affect nsph formation. Heating alone also
did not compromise the stimulatory effect of nsph-CM. Thus, the
reduction in the stimulatory effect of nsph-CM is due to chABC
digestion of CSPGs in the nsph-CM, and not to the enzyme acting
directly on the cells or heat inactivation of the nsph-CM. To
confirm the role of ApoE we used the receptor-associated protein
(RAP) to block ApoE binding to its receptor. This reduced the
nsph stimulatory effect of nsph-CM by 60% (Fig. 2E). When both
CSPG and ApoE were inhibited, the nsph stimulatory effect of
nsph-CM was completely abolished (Fig. 2F). Thus both CSPG
and ApoE are responsible for the nsph stimulatory effect of nsph-
CM. In this study we focus on the role of CSPG in NSC survival
and growth, while the role of ApoE was investigated elsewhere
(submitted).
CSPG is essential for nsph formation and proliferation
To determine whether the increase in nsph formation is specific
to CSPG, we tested both exogenous addition of proteoglycans and
inhibition of endogenous proteoglycans. Exogenous CSPG was
able to stimulate nsph formation in a dose-dependent manner
whereas another proteoglycan, keratan sulfate (KS), had no effect
(Fig. 3A). Digesting the CS-GAG chains with chABC resulted in a
dose-dependent reduction in nsph formation (Fig. 3B), whereas
Figure 2. CSPG and ApoE are the components of nsph-CM responsible for stimulation of nsph formation. (A) Fractions A and B of
nsph-CM were further fractionated into six fractions by size using liquid chromatography as shown. Cells were plated at 2610
3 cells/ml and NFUs
measured after five days of culture as described in figure 1 with the following variations; (B) Addition of GM, nsph-CM or sub-fractions 1–6. Nsph-CM
and sub-fractions 1–6 were reconstituted into GM to the original concentration prior to cell culture. (C) Addition of GM, nsph-CM, CSPG (50 mg/ml),
ApoE (50 nM) or cystatin C (20 ng/ml). (D) Addition of GM and nsph-CM alone with and without heat inactivation, or GM and nsph-CM pre-digested
with chABC (50 mU/ml) and heat inactivated. (E) Addition of GM and nsph-CM with and without recombinant receptor associated protein (RAP;
5 mM). (F) Addition of GM, nsph-CM, with and without chABC (50 mU/ml) treatment (including heat inactivation, see Materials and Methods) and RAP
(5 mM). Data are presented as mean 6 SEM with n=4–11 (from 2–4 experiments); *P#0.05, **P#0.01 compared to GM or as indicated on the graphs.
doi:10.1371/journal.pone.0015341.g002
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formation even when used at 10 times the maximum concentra-
tion of chABC. This supports the idea that nsph formation
specifically requires CSPG. The chABC treatment not only
inhibited nsph formation but also disrupted the 3D structure of
any nsphs that formed (Fig. S1). To ensure that the reduction in
nsph formation is not due to non-specific interference of the nsph
structure, we also disrupted CSPG biosynthesis with sodium
chlorate and b-D-xyloside. Both compounds were able to inhibit
nsph formation similar to chABC but without any disruption to
the nsph structure (Fig. 3C). Furthermore, addition of CSPG was
able to partially rescue the inhibitory effect of all three CSPG
inhibitors (Fig. 3C). The rescue effect in the presence of chABC is
likely due to exogenous CSPG saturating the enzyme added.
In free-floating cultures cell aggregation can occur [18,22]. This
can promote nsph formation in cells that may not have intrinsic
nsph forming abilities, complicating the analysis. To test whether
CSPG can stimulate nsph formation under non-aggregating
conditions, a hydrogel culturing system was used to immobilize
cells. Similar to low density suspension cultures, both nsph-CM
and CSPG stimulated nsph formation in hydrogel cultures, and
their effects were comparable (Fig. 3D). Thus both nsph-CM and
CSPG directly stimulate nsph formation in the absence of cell
aggregation. The stimulatory effect of CSPG was temporary.
When CSPG-generated nsphs were dissociated and replated
without CSPG, nsph formation rate returned to control levels
(Fig. 3E). CSPGs are known to function mainly through their
GAG chains. Indeed we found that the GAGs CS-A, B and E can
promote nsph formation whereas CS-C and -D had no effect
(Fig. 3F). Images of all cell culture conditions are presented in
figure S1.
In addition to stimulating nsph formation, exogenous CSPG
increased total cell number (Fig. S2A) and nsph size (Fig. S2D).
The increase in nsph size was observed in both suspension cultures
and immobilized hydrogel cultures. Thus CSPG increases nsph
size as a result of increased proliferation rather than aggregation.
Inhibiting endogenous CSPG with chABC, chlorate and xyloside
also reduced cell numbers (Fig. S2B) and nsph size (Fig. S2E). The
ability of chABC to break down the 3D structure of the nsphs
suggests that CSPG is involved in maintaining the nsph structure.
Endogenous CSPG may regulate cell proliferation as a result of its
structural function, i.e. holding the cells in close contact allows cell-
cell signaling to stimulate proliferation. To investigate this
possibility we switched to an adherent monolayer culture system.
Again, chABC, chlorate and xyloside treatment inhibited NSC/
NP proliferation, while CSPG increased proliferation (Fig. S2C).
Figure 3. Specificity of CSPG mediated stimulation of nsph formation. Cells were plated at 2610
3 cells/ml and NFUs measured after five
days of culture as described in figure 1 (except D). Data shown in the bar charts (A–F) examine the effect of the following on NFUs; (A) CSPG (10–
50 mg/ml) and keratin sulfate (KS; 50 mg/ml). (B) ChABC (10–50 mU/ml) and keratinase (Kerase; 10–500 mU/ml). (C) GM, CSPG (50 mg/ml); xyloside
(150 mM), chlorate (50 mM) and chABC (50 mU/ml) with and without CSPG (50 mg/ml). (D) The effect of GM, nsph-CM and CSPG (50 mg/ml) on NFUs
measured in hydrogel. Cells were plated at 2.5610
3 cells/ml in hydrogel medium (see Material & Methods) and NFU measured after five days.
(E) Nsphs grown in the presence of CSPG were dissociated and replated at 2610
3 cells/ml with and without CSPG (50 mg/ml). Secondary nsph
formation was evaluated after five days. (F) GM, CSPG (50 mg/ml), chondroitin sulfate A–E (CS-A to CS-E; all at 50 mg/ml). Data are presented as mean
6 SEM with n=3–12 (from 2–4 experiments); ** P#0.01.
doi:10.1371/journal.pone.0015341.g003
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its nsph structural role. Analysis of cell population doubling time
show that CSPG significantly reduces the population doubling
time of low density nsph assays (NSA) and adherent cultures, while
CSPG inhibitors increased the doubling times in all culture
conditions (Fig. S2F).
CSPG stimulates NSC survival
Both NSCs and NPs can form nsphs [23]. To determine
whether CSPG was affecting NSC survival it was critical to assess
CSPG-generated nsphs for their self-renewal and multipotent
characteristics. CSPG-treated cells can be passaged for at least
seven passages similar to control cells, but gave rise to more cells
(Fig. 4A). To score for multipotency, we differentiated individual
nsphs generated from clonal low density cultures. Upon differen-
tiation, 17.864.4% of control nsphs were found to be multipotent,
producing neurons, oligodendrocytes and astrocytes (Fig. 4B & D).
CSPG treatment significantly increased the percentage of tripotent
nsphs by 11.7%, and decreased the percentage of unipotent
(astrocyte only) nsphs by 10.6% as compared to the control. The
percentage of bipotent nsphs, neurons/astrocytes or oligodendro-
cytes/astrocytes, were unaffected (Fig. 4B). Astrocytes were always
present, thus there were no neuron/oligodendrocyte bipotent
nsphs.
We further characterized the nature of CSPG-generated nsphs
by gene profiling individual nsphs and using the neural colony-
forming cell assay (NCFCA). A panel of genes related to NSCs
remained largely unchanged. Significant increases were observed
for Hes1, Nestin and Ki67 (Fig. 4C). The NCFCA is based on the
hypothesis that NSCs have greater proliferative potential and will
give rise to larger colonies than progenitors [24]. CSPG-treated
cells generated fewer colonies between 0.5 and 0.8 mm in
diameter, with a significant increase in colonies between 0.8 and
1.2 mm as compared to the control (Fig. S3A). Conversely
chABC, chlorate and xyloside treatment increased the percentage
of colonies smaller than 0.5 mm and decreased percentage of
colonies in the 0.5–1 mm category (Fig. S3B). Taken together,
these observations on self-renewal, multipotency, gene expression
and colony formation suggest that CSPG increases NSC survival.
In support of this survival role, cells incubated with CSPG or CS-A
to -E for 24 hours showed significantly less active caspase 3/7 as
compared to untreated cells (Fig. 4E). Conversely, chABC,
chlorate and xyloside treatments for 24 hours significantly
increased the percentage of TUNEL positive cells (Fig. 4F). To
evaluate the effect of CSPG on NSC survival, we calculated the
NSC frequency as a product of clonal NFU and multipotent nsph
percentage. CSPG treatment increased the NSC frequency by
more than four-fold (Fig. 4G).
CSPG stimulates ESC-derived nsph formation
ESCs can spontaneously form nsphs at a very low frequency
when cultured in NSC growth medium. We next asked whether
CSPG also affects ESC-derived nsphs. Addition of exogenous
CSPG increased the percentage of ESC-derived nsphs (Fig 5A).
The CSPG-generated ESC-derived NSCs were more than 90%
nestin positive (n=5) and can differentiate into neurons,
oligodendrocytes and astrocytes (Fig 5C). To determine whether
CSPG increased ES-derived nsph formation by directed differen-
tiation or by expanding the pool of cells already committed to the
neural lineage, we assessed the effects of CSPG on ESCs cultured
in ESC medium without LIF. Under this culture condition, ESCs
differentiate randomly into cells of the three germ layers as
indicated by the expression of endoderm genes (Sox17 and Gata4),
mesoderm genes (Eomeso and Brachyury) and ectoderm genes
(Sox1 and Sox3; data not shown). CSPG treatment did not alter
this differentiation process since no persistent changes in the
expression of these genetic markers were observed (Fig. 5B). The
expression level of pluripotent genes (Nanog and Oct3/4) was also
not significantly altered. This suggests that CSPG did not induce
differentiation of ESCs into NSCs but possibly promoted survival
and proliferation of committed NSCs/NPs.
CSPG stimulates nsph formation via enhancement of
EGFR, JAK and PI3K signaling
To begin to understand how CSPG may signal within NSCs, we
analyzed the EGFR and Rho pathways. The EGFR pathway is
essential for NSC survival and proliferation while CSPG is known
to signal via Rho/ROCK [25]. Since nsph formation is a long-
term process, we used inhibitors of EGFR and Rho/ROCK
signaling to determine the effect on nsph formation in the presence
of CSPG. Inhibition of EGFR kinase activity with PD168393
reduced nsph formation in both control and CSPG treated
cultures (Fig. 6A). The IC50 values for nsph formation (IC50NF)o f
PD168393 for control and CSPG-treated cells are 5.8761.7 nM
and 2.8360.89 nM respectively (means 6 SEM, P#0.05). Thus
the concentration of PD168393 required to reduce 50% of nsph
formation is significantly less for CSPG-treated cells than control,
indicating that CSPG stimulation of nsph formation may be
preferentially inhibited over basal nsph formation. Stimulation of
EGFR leads to the activation of PI3K, JAK and ERK. Inhibition
of PI3K with LY294002 significantly reduced CSPG-stimulated
nsph formation (Fig. 6B). The IC50NF of LY294002 for control
and CPSG-treated cells are 3.7860.4 mM and 2.9760.23 mM
respectively (means 6 SEM, P#0.05). Inhibition of JAK with
AG490 also reduced CSPG-stimulated nsph formation (Fig. 6C).
The IC50NF of AG490 for control and CSPG-generated cells are
0.460.069 mM and 0.3360.064 mM respectively (means 6 SEM,
P#0.05). Conversely, inhibition of ERK with PD98059 (Fig. 6D)
gave similar IC50NF values for control and CPSG-treated cells,
12.460.18 mM and 12.860.69 mM respectively. This indicates
that PD98059 is inhibiting control and CSPG-treated cells at the
same rate. Inhibition of Rho GTPases with C3 transferase was
able to inhibit nsph formation in control cultures. However, in the
presence of CSPG, C3 had minimal effect on nsph formation
(Fig. 6E). The Rho kinase inhibitor Y27632 was also unable to
abolish CSPG stimulation of nsph formation (Fig. 6F). The
IC50NF of Y27632 for control and CSPG-generated cells are
4.2460.68 mM and 59.662 mM respectively (means 6 SEM,
P#0.001).
Further analysis of the inhibitor data show that the concentra-
tion of LY294002, AG490 and PD168393 that abolished the
CSPG stimulatory effect only inhibited nsph formation in control
cultures by 10, 20 and 30%, respectively (Fig. S4). In contrast, the
concentration of PD98059 that abolished the CSPG stimulatory
effect reduced nsph formation in control cultures by 79%. While
for Y27632, no nsph formation occurred at 50 mM, the
concentration required to inhibit the CSPG stimulatory effect.
This suggests that CSPG preferentially signals through PI3K, JAK
and EGFR.
CSPG stimulates EGFR signaling pathways
Next we use Western analysis to determine whether CSPG can
directly stimulate the EGFR signaling pathways. CSPG directly
stimulated EGFR phosphorylation (Fig. 7A) after 30 minutes
(1.460.08 fold relative to control, P#0.05). However, CSPG did
not enhance EGF stimulation of EGFR. Although there is a trend
for reduced EGFR phosphorylation at the 60 minutes time point
with CSPG and EGF stimulation compared to EGF alone, the
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15341Figure 4. CSPG stimulates NSC survival. (A) Cells were plated at 2610
3 cells/ml with CSPG (50 mg/ml) or without (control). Nsphs were passaged
every seven days with cells replated at the same density and treatment conditions. Cell numbers were counted at each passage and plotted against
passage number. (B) Statistical analysis of the multipotency of individual nsphs. Individual clonal nsphs grown with or without CSPG (50 mg/ml) were
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PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15341difference is not significant when results from multiple experiments
were combined as the error bars were large. Specific phospho-
EGFR antibodies revealed that CSPG stimulates EGFR phos-
phorylation at tyrosine 1068 (Fig. 7D). CSPG stimulated STAT3,
a downstream effector of JAK, within three hours (Fig. 7B). EGF
alone also stimulated STAT3 phosphorylation as expected. In cells
pretreated with CSPG, EGF induced further stimulation of
STAT3 which approximated the sum of the individual stimulants
alone. This result is significant when multiple experiments were
combined (P,0.05). After six days in culture, CSPG-generated
cells showed a significant increase in the levels of EGFR and
phospho-EGFR (Fig. 7C), as well as an increase in the levels of Akt
and phospho-Akt, a downstream effector of PI3K (Fig. 7E). CSPG
did not directly stimulate Akt phosphorylation in short term
experiments, nor affected ERK and phospho-ERK levels in either
short or long term cultures (data not shown). Together these results
suggest that CSPG can directly stimulate phosphorylation of
EGFR and STAT3, as well as upregulate the long term expression
of EGFR and Akt.
Discussion
The present work began with the observation that mouse E14.5
nsph-CM stimulates nsph formation. Following mass spectrometry
identification of CSPG, ApoE and cystatin C, we showed by both
inhibition of endogenous protein and reconstitution with exoge-
nous protein that CSPG and ApoE can fully account for the nsph
stimulatory effect of nsph-CM. Although we did not inhibit
cystatin C in the nsph-CM, we reasoned that cystatin C is unlikely
to play a stimulatory role since neither the nsph-CM fraction that
is likely to contain cystatin C (sub-fraction 6), nor reconstitution
with exogenous cystatin C were able to stimulate nsph formation.
Previously, cystatin C was isolated from adult rat hippocampal
progenitor-CM and demonstrated to stimulate NSC/NP prolifer-
ation and clone formation [3]. A possible reason for the differences
in our data could be the embryonic NSCs/NPs that we use do not
require cystatin C for nsph formation whereas this protein is more
essential for adult NSCs/NPs. It is well known that NSCs/NPs
alter their responses to growth factors over time [26].
To confirm the involvement of CSPG we showed that addition
of pure CSPG can recapitulate the effect of nsph-CM and
stimulates nsph formation and proliferation under clonal condi-
tions. On the other hand, digestion of CSPG with chABC
inhibited nsph formation. A recent publication showed that
chABC inhibits FGF-dependent but not EGF-dependent nsph
formation [27]. We find this difficult to reconcile since our cells are
cultured in EGF only media and we observe a dose-dependent
inhibition of nsph formation with chABC. We can only speculate
that this may arise from experimental differences.
We found that the effects on nsph formation are specific to
CSPG since neither exogenous addition of KS-GAG nor
disruption of endogenous KS-GAG affected nsph formation.
Interestingly inhibition of CSPG with chABC not only reduces
nsph formation but also disrupts the integrity of the nsph structure.
CSPG is thought to function through its CS-GAGs to form a
major component of the perineuronal net (PNN), a specialized
ECM in the CNS which is involved in both synaptic and structural
plasticity of the brain [28]. Furthermore, intraventricular injection
of chABC disrupts the organization of the embryonic ventricular
zone [17]. Thus CS-GAG chains are likely to be crucial for
maintaining the structure of nsphs in vitro and the neurogenic zone
in vivo. Indeed, we found that the CS-GAGs alone can stimulate
nsph formation. Previously, CS-B, -D and -E units have been
shown to promote FGF-2-mediated proliferation of rat embryonic
NSCs/NPs [29]. Here, we show that CS-A, -B and -E stimulates
nsph formation in EGF-dependent mouse embryonic NSCs/NPs,
whereas CS-C and -D does not. Thus CSPG can modulate nsph
formation using different sulfation motifs.
CSPG stimulates NSC survival
One of the key questions that have not been addressed is the
role of cell-secreted CSPGs in NSC/NP survival. The defining
features of an NSC include self-renewal and multipotency. In vitro,
self-renewal is often measured by the ability of NSCs to generate
secondary nsphs. However, nsph formation is not a property
restricted to NSCs as NPs can also form nsphs [30]. As for
evaluation of multipotency, when differentiation is performed
using dissociated cells, or a pool of nsphs, it is not possible to
determine whether the multiple cell types obtained came from
tripotent, bipotent or unipotent nsphs. The first type of nsphs will
suggest the presence of NSCs whereas the later two indicates the
presence of NPs. Thus CSPG-generated nsphs were evaluated in
terms of; (a) the ability to survive long-term passage, since
progenitor-derived nsphs have limited self-renewal capacity [31],
and (b) the ability of individual clonal nsphs to give rise to different
lineages. We showed that CSPG-generated cells can be serially
passaged for at least seven passages, thus fulfilling the NSC
criterion of extensive self-renewal. Differentiation of individual
clonal nsphs showed that CSPG treatment increases the
percentage of tripotent nsphs. Together these data indicate that
CSPG specifically increases NSC survival. In support of this
survival role both CSPG and CS-GAGs decreased active caspase
3/7 level. Using the NCFCA we showed that CSPG treatment did
not alter the percentage of .2 mm colonies (putative stem cell-
derived colonies [24]). However, CSPG stimulated nsphs did form
larger colonies (0.8-1.2 mm) compared to untreated neural
progenitors. The lack of changes in the .2 mm colonies is likely
due to the low density and minimal medium culturing system that
we use compared to the high density and enriched medium
cultures as recommended by the original authors [24]. Neverthe-
less, our data indicates greater proliferation upon CSPG
stimulation and is consistent with CSPG increasing NSC
differentiated (see Materials and Methods) and scored as follows; tripotent (neurons, astrocytes and oligodendrocytes), bipotent (neurons/astrocytes
or oligodendrocytes/astrocytes), unipotent (astrocytes). Data are presented as mean 6 SEM with n$347 (from 6 experiments); * P#0.05, ** P#0.01.
(C) Gene expression of individual clonal nsphs grown with or without CSPG (50 mg/ml) was measured by quantitative RT-PCR as described in the
supplementary Materials and Methods S1. The bar chart show changes in gene expression induced by CSPG with a value of 1 indicating no change.
Data are presented as mean 695% confidence interval with n$70 (from 3–10 experiments). (D) Representative images of differentiated nsphs
stained for the lineage markers O4 (oligodendrocyte; green), Tuj1 (neuron, red) and GFAP (astrocyte, gray). Nuclei were counterstained with DAPI
(blue). The merged image shows co-localization of all three cell types. Scale bar =50 mm at 20X objective. (E) Dissociated cells were plated at bulk
density in GM with or without CSPG or CS-A to –E (all at 50 mg/ml) for 24 hours. Bar chart shows active caspase 3/7 level as determined by the
Caspase-Glo 3/7 kit. (F) Dissociated cells were plated onto PLL coated coverslips at 5610
5 cells/13 mm coverslip in GM containing chABC (20 mU/ml),
chlorate (50 mM) or xyloside (150 mM) for 24 hours. Cells were fixed and stained with DeadEnd Fluorometric TUNEL kit. Bar chart shows percentage
of TUNEL positive cells with each treatment. Data are presented as means 6 SEM with n$9 (from 4–5 experiments); * P#0.05, ** P#0.01 compared to
control, bar represent same significance level compared to control. (G) NSC frequency was calculated by multiplying NFUs with the percentage of
multipotent nsphs.
doi:10.1371/journal.pone.0015341.g004
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When CSPG-generated nsphs were dissociated and replated
without CSPG, nsph formation rate returned to control levels.
This suggests that CSPG acts as a survival factor for existing NSCs
rather than promotes NSC self-renewal.
The NSA has been widely used to study NSCs. But when used
alone, it cannot enumerate the NSC frequency. The enumeration
of NSC frequency requires demonstration of clonality and
multipotency in the same nsph. Using clonal nsphs we have
demonstrated the presence of multipotent nsphs. Based on these
data, we estimated that the NSC frequency is 0.6160.3% and
CSPG increases this frequency by more than four-fold (Fig. 4E),
indicating that CSPG is increasing NSC survival.
Previously cystatin C, a factor present in the nsph-CM, have
been shown to stimulate NSC formation from ESCs [4–5]. Here
we show that in addition to its effect on NSCs, CSPG also
stimulates nsph formation from ESCs. CSPG does not stimulate
the differentiation of ESCs, thus it is likely to enhance the
survival of ESC-derived NSCs similar to its effect on brain-
derived NSCs. Given the low rate at which ESCs normally
convert to nsphs (0.2%), addition of CSPG represents a useful
tool to generate ESC-derived NSCs, and will assist in delineating
Figure 5. CSPG stimulates nsph formation from ESC. (A) ESC cells were cultured at 10
5 cells/ml with or without CSPG (20–100 mg/ml) in nsph
growth medium and NFUs measured after 21 days. Data are presented as mean 6 SEM with n$3 (from 1 representative experiment). Similar results
were obtained in two other experiments. (B) Expression analysis of pluripotency genes (Nanog and Oct3/4), endoderm genes (Sox17 and Gata4),
mesoderm genes (Eomeso and Brachyury) and ectoderm genes (Sox1 and Sox3) was measured by quantitative RT-PCR as described in the
supplementary Materials and Methods S1. The bar chart shows CSPG (50 mg/ml) induced changes in gene expression relative to control with a value
of 1 indicating no change. Data are presented as mean 6 95% confidence interval with n=8 (from 4 experiments). (C) Undifferentiated ESC-derived
nsphs and E14.5 nsphs were stained for nestin. Both types of nsphs were dissociated for differentiation and stained for lineage markers as described
in figure 4 and the supplementary Materials and Methods S1. Scale bar =50 mm at 20X objective.
doi:10.1371/journal.pone.0015341.g005
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to NSC.
CSPG stimulates nsph formation via enhancement of
EGFR, JAK/STAT3 and PI3K/Akt signaling
To determine which signaling pathway(s) may be involved in
CSPG’s effect on NSC survival we carried out both short and long
term assays. The EGFR and Rho signaling pathways were selected
since EGF is known to be required for nsph propagation and CSPG
signals via RhoA in neurons. The inhibitor studies suggest EGFR,
JAK and PI3K are the most likely proteins through which CSPG
signals, since the stimulatory effect of CSPG can be abolished with
inhibitors of these pathways at concentrations that had minimal
effect on control cultures. Reduced IC50NF values were also
observed for CSPG cultures. In contrast, inhibition of MEK, RhoA
and ROCK either did not affect CSPG stimulation (RhoA) or
inhibits CSPG stimulation at concentrations that produced near-
complete or complete inhibition of nsph formation in control
cultures (MEK and ROCK respectively). This suggests that CSPG is
unlikelytosignal via MEK,RhoA and ROCK.The inhibitorstudies
are supported by the observations that CSPG can directly stimulate
EGFR and STAT3 phosphorylation, as well as regulate long-term
expression of EGFR and Akt. Since the direct stimulation of EGFR
phosphorylationisminimalandnotapparentinthepresenceofEGF
it is likely that the long-term upregulation of EGFR expression is
more important for CSPG signaling. Similarly CSPG may signal via
the PI3K/Akt pathway by long-term upregulation of Akt expression
rather than directly stimulating this protein.
The EGFR and PI3K/Akt pathways are known to be involved in
nsph formation and NSC/NP proliferation [32–34]. CSPG has also
been shown to regulate EGFR [35–38], and PI3K/Akt [39–42]
signaling independently in various cell types. However, the work
presented here demonstrates that CSPG may enhance signaling of
both proteins in NSCs. The JAK/STAT pathway has also been
demonstrated in NSCs/NPs [43–44], and a recent article indicates
that CS-A can stimulate STAT3/4 gene expression in splenocytes
[45]. Our data suggest that this pathway, CSPG stimulation of
STAT3, also occurs in NSCs. However, our data shows that a
combination of CSPG and EGF produced greater stimulation of
STAT3 than the individual stimulants. This suggests that CSPG
may enhance STAT3 signaling via pathways besides EGFR.
Cytokines activate the JAK/STAT pathway via the glycoprotein
receptor gp130 [46]. This pathway is involved in neurogenesis and
NSC self-renewal [47–48]. The gp130 receptor may be a potential
route through which CSPG can stimulate JAK/STAT to promote
NSC survival. More recently, the integrin pathway has also been
Figure 6. Effect of inhibitors of EGFR and RhoA signaling pathways on NFUs. Cells were grown at 2610
3 cells/ml, inhibitors added at the
indicated concentrations and nsph formation followed for five days in the presence or absence of CSPG (50 mg/ml). (A) EGFR kinase inhibitor
PD168393 concentration range (50 pM–50 nM). (B) PI3K inhibitor LY294002 concentration range (25 nM–25 mM). (C) JAK inhibitor AG490
concentration range (6.25 nM–6.4 mM). (D) ERK inhibitor PD98059 concentration range (100 nM–200 mM). (E) RhoA inhibitor C3 concentration range
(25 ng/ml–25 mg/ml). (F) Rho kinase inhibitor Y27632 concentration range (50 nM–50 mM). Data are presented as mean 6 SEM, n=3 from 1
representative experiment. Similar results were obtained in two other experiments.
doi:10.1371/journal.pone.0015341.g006
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cells [49]. Thus CSPG may signal via multiple pathways to regulate
neural progenitor growth and differentiation.
Conclusion
CSPGs are involved in CNS injury and inhibition of
regeneration [50]. The findings reported here of CSPG stimula-
tion of NSC survival and proliferation suggest that CSPG could
aid in brain repair. How can these distinct functions of CSPG be
rationalized? One possible explanation is that the barrier property
of CSPGs is involved in both inhibition of regeneration and
maintenance of NSCs. CSPG is thought to inhibit neuroregenera-
tion by regulating the availability of growth factors to the growing
axons as well as through direct signaling pathways [51]. CSPGs
may also form barriers around NSCs and regulate proliferation,
differentiation and apoptotic signals to maintain the NSC state.
Such a model has been proposed for CSPG maintenance of the
articular cartilage stem cell niche [52]. We have shown here that
CSPG is an essential component of the nsph-CM. It is involved in
regulating NSC survival and proliferation, in nsph formation and
maintenance, possibly via enhancement of EGFR, JAK/STAT3
and PI3K signaling pathways.
Supporting Information
Materials and Methods S1 Material and methods for
apoptosis assays, single nsph gene profiling, neural colony forming
cell assay and dissociated cell differentiation.
(DOC)
Figure 7. CSPG stimulates EGFR signaling pathways. Kinase activity was estimated by using Western analysis. Whole cell lysates were
separated by SDS-PAGE and probed with phosphotyrosine antibodies; PY20, p-Akt, p-EGFR (1068), and p-STAT3. The respective total protein signal
was used to normalize protein loading. For each figure, the images are representative Western blots while the bar charts below show quantification
of signals expressed relative to control. Data are presented as mean 6 SEM with n$4 (from $3 experiments); * P#0.05, ** P#0.01 compared to
control (con) or as indicated on the graphs. (A) Nsphs were dissociated into single cells and cultured in growth medium without EGF for three hours
followed by stimulation with EGF (20 ng/ml), CSPG (50 mg/ml) or both for 10 to 60 min. EGFR activation status as seen by PY20. (B) Cells were
cultured as in (A) followed by stimulation with EGF (20 ng/ml) for 30 min or CSPG (50 mg/ml) for three hours. Cells pretreated with CSPG (50 mg/ml)
for three hours were stimulated with EGF (20 ng/ml) for 30 min (CSPG + EGF). STAT3 activation status as seen by p-STAT3. (C) Cells were cultured for
six days in the presence of EGF (20 ng/ml), with or without CSPG (50 mg/ml). EGFR activation status as seen by PY20 and EGFR levels. (D) Cells were
cultured as in (C) and EGFR phosphorylation at tyrosine residue 1068 was evaluated using the p-EGFR (1068) antibody. (E) Cells were cultured as in (C)
and Akt activation status as seen by p-Akt and Akt levels.
doi:10.1371/journal.pone.0015341.g007
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PLoS ONE | www.plosone.org 11 December 2010 | Volume 5 | Issue 12 | e15341Figure S1 Images of cell culture systems. Dissociated cells
were cultured in suspension, in hydrogel or on poly-L-lysine
coated dishes to form adherent cultures. For control and CSPG
(50 mg/ml) treated cultures, cells were plated at 2610
3 cells/ml.
CSPG treatment stimulated proliferation in all culture conditions.
For chABC (20 mU/ml) treated cultures, cells were plated at
2610
4 cells/ml. ChABC brokedown the 3D nsph into loss cell
clusters (arrow, left panel) and induced cell attachment and
proliferation as an adherent layer (right panel). Arrow head in the
left panel marks a normal nsph. Scale bar =100 mm at 10X
objective.
(TIF)
Figure S2 CSPG treatment increased NSC/NP prolifer-
ation. Cells were cultured in suspension at 2610
3 cells/ml (A) and
2610
4 cells/ml (B) or as adherent culture (C;1 610
4 cells/ml).
The treatment conditions were CSPG (50 mg/ml), chABC
(50 mU/ml), sodium chlorate (20 mM) or xyloside (150 mM).
Total viable cells were determined on alternate days with the
CellTitre Glo assay kit (Promega) measuring ATP level in viable
cells by bioluminescence signals. Graphs show luminescence level
against days in vitro. (D) and (E) The diameter of nsphs grown
with and without CSPG (50 mg/ml), chABC (50 mU/ml), sodium
chlorate (20 mM) or xyloside (150 mM) in suspension culture were
measured and divided into three categories, ,50 mm, 50–100 mm
and .100 mm. Graph show percentage of nsph in each size
category. For (D) nsph diameter was also measured in hydrogel.
(F) Population doubling time (hours) for cells cultured under
different conditions calculated from the above experiments using
the GraphPad Prism software. Data are presented as mean 6
SEM with n$6 (from 2–6 experiments); *P#0.05, **P#0.01
compared to the control in each size category for (D) and in each
density for (F); a=P#0.01 compared to control and b=P#0.01
compared to inhibitor only cultures in (E); N.D., not determined;
NS, not significant.
(TIF)
Figure S3 Neural colony forming assay. (A) Nsphs grown
with or without CSPG (50 mg/ml) for seven days were dissociated
and plated at 2.5610
3 cells/ml in NCFCA collagen medium.
Colony number and size were recorded after three weeks. The bar
chart shows the percentage of colonies above 0.5 mm in diameter.
(B) Nsphs grown with or without chABC (50 mU/ml), sodium
chlorate (20 mM) or xyloside (150 mM) for four days were
analyzed as in (A). The bar chart shows the percentage of colonies
in each size category. Data are presented as means 6 SEM; n$20
(from 5 experiments); * P#0.05, ** P#0.01 as compared to
control, bar represent same significance level compared to control.
(TIF)
Figure S4 Interpretation of chemical inhibition data.
(A) Diagram illustrating estimation of the inhibitor concentration
that abolishes the stimulatory effect of CSPG (S) and its effect on
control nsph formation rate. (B) Table summarizing the
estimations from diagram (A) for each inhibitor as well as the
IC50 values for nsph formation (IC50NF). Data are presented as
means 6 SEM with n=9 (from 3 experiments); *P#0.05,
**P#0.01 compared to control; NS, not significant.
(TIF)
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